KR102515641B1 - 코팅된 입자의 제조 방법 - Google Patents

코팅된 입자의 제조 방법 Download PDF

Info

Publication number
KR102515641B1
KR102515641B1 KR1020197023311A KR20197023311A KR102515641B1 KR 102515641 B1 KR102515641 B1 KR 102515641B1 KR 1020197023311 A KR1020197023311 A KR 1020197023311A KR 20197023311 A KR20197023311 A KR 20197023311A KR 102515641 B1 KR102515641 B1 KR 102515641B1
Authority
KR
South Korea
Prior art keywords
core
weight
coated particles
total weight
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197023311A
Other languages
English (en)
Korean (ko)
Other versions
KR20190117520A (ko
Inventor
지하네 아크카르
엘거 푼다
로니 슈바이케르트
카이 우르반
올리비아 브리기테 비도니
에른스트 제디
Original Assignee
디에스엠 아이피 어셋츠 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디에스엠 아이피 어셋츠 비.브이. filed Critical 디에스엠 아이피 어셋츠 비.브이.
Publication of KR20190117520A publication Critical patent/KR20190117520A/ko
Application granted granted Critical
Publication of KR102515641B1 publication Critical patent/KR102515641B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
KR1020197023311A 2017-02-20 2018-02-16 코팅된 입자의 제조 방법 Active KR102515641B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17156871.0 2017-02-20
EP17156871 2017-02-20
PCT/EP2018/053855 WO2018149952A1 (en) 2017-02-20 2018-02-16 Process for producing coated particles

Publications (2)

Publication Number Publication Date
KR20190117520A KR20190117520A (ko) 2019-10-16
KR102515641B1 true KR102515641B1 (ko) 2023-03-30

Family

ID=58185260

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197023311A Active KR102515641B1 (ko) 2017-02-20 2018-02-16 코팅된 입자의 제조 방법

Country Status (8)

Country Link
US (1) US10966934B2 (cg-RX-API-DMAC7.html)
EP (1) EP3582758A1 (cg-RX-API-DMAC7.html)
JP (1) JP6977957B2 (cg-RX-API-DMAC7.html)
KR (1) KR102515641B1 (cg-RX-API-DMAC7.html)
CN (1) CN110325177A (cg-RX-API-DMAC7.html)
AU (1) AU2018222638B2 (cg-RX-API-DMAC7.html)
NZ (1) NZ755788A (cg-RX-API-DMAC7.html)
WO (1) WO2018149952A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022398127A1 (en) 2021-11-29 2024-06-06 Chr. Hansen A/S Fat and wax microencapsulated ambient stable bacteria and probiotics
US20250325487A1 (en) * 2021-12-17 2025-10-23 Dsm Ip Assets B.V. New coating system (i)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010111347A2 (en) * 2009-03-26 2010-09-30 Advanced Bionutrition Corporation Microencapsulation of bioactive substances and methods of making the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US5059416A (en) * 1989-06-26 1991-10-22 Warner-Lambert Company Zinc compound delivery system with improved taste and texture
US5230822A (en) * 1989-11-15 1993-07-27 Lever Brothers Company, Division Of Conopco, Inc. Wax-encapsulated particles
US5200236A (en) * 1989-11-15 1993-04-06 Lever Brothers Company, Division Of Conopco, Inc. Method for wax encapsulating particles
US5258132A (en) * 1989-11-15 1993-11-02 Lever Brothers Company, Division Of Conopco, Inc. Wax-encapsulated particles
EP0598920B1 (en) * 1992-06-16 1998-01-14 Fuji Oil Co., Ltd. Emulsifier, emulsifying composition and powdery composition
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6025315A (en) * 1999-03-25 2000-02-15 Colgate Palmolive Company Automatic dishwashing tablets
EP1066836A1 (en) * 1999-06-11 2001-01-10 Sensus, part of Coöperatie COSUN U.A. Filler/binder hollow particles for tablets
US20040043070A1 (en) * 2002-05-14 2004-03-04 Ayres James W. Hot melt coating by direct blending and coated substrates
FR2851734B1 (fr) * 2003-02-28 2006-06-09 Galenix Innovations Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
US20080085318A1 (en) * 2005-07-16 2008-04-10 Cherukuri S R Coated compositions and methods for preparing same
KR102170339B1 (ko) * 2011-10-14 2020-10-27 디에스엠 아이피 어셋츠 비.브이. 신규 코팅 시스템
US11033500B2 (en) * 2015-10-02 2021-06-15 Dsm Ip Assets B.V. Process for the production of compressed tablets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010111347A2 (en) * 2009-03-26 2010-09-30 Advanced Bionutrition Corporation Microencapsulation of bioactive substances and methods of making the same

Also Published As

Publication number Publication date
AU2018222638A1 (en) 2019-08-15
NZ755788A (en) 2022-05-27
WO2018149952A1 (en) 2018-08-23
AU2018222638B2 (en) 2023-03-16
EP3582758A1 (en) 2019-12-25
KR20190117520A (ko) 2019-10-16
JP2020508291A (ja) 2020-03-19
US20190380971A1 (en) 2019-12-19
JP6977957B2 (ja) 2021-12-08
US10966934B2 (en) 2021-04-06
BR112019017073A2 (pt) 2020-04-07
CN110325177A (zh) 2019-10-11

Similar Documents

Publication Publication Date Title
Martinez et al. Oxidative stability of walnut (Juglans regia L.) and chia (Salvia hispanica L.) oils microencapsulated by spray drying
Fuchs et al. Encapsulation of oil in powder using spray drying and fluidised bed agglomeration
KR102170339B1 (ko) 신규 코팅 시스템
US11564887B2 (en) Process for the production of compressed tablets
EP0944675A1 (de) Stabile, wässrige dispersionen und stabile, wasserdispergierbare trockenpulver von xanthophyllen, deren herstellung und verwendung
JP2023002728A (ja) 固体粒子
US20170143017A1 (en) Beadlets comprising carotenoids
US20180343909A1 (en) Vitamin formulation
US10966934B2 (en) Process for producing coated particles
EP3346992B1 (en) Process of production of a formulation comprising therapeutically active or nutritious plant extracts
EP3487319B1 (de) Propylgallathaltige vitaminzubereitungen
BR112019017073B1 (pt) Processo para produzir partículas revestidas
JP2020508291A5 (cg-RX-API-DMAC7.html)
EP3363429A1 (en) Process for the production of coated particles
BR112018006544B1 (pt) Processo para a produção de comprimidos prensados e comprimidos prensados

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000